자동화 및 밀폐형 세포치료 처리 시스템 시장 규모, 점유율, 성장 분석 : 시스템 유형별, 기술별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Automated And Closed Cell Therapy Processing Systems Market size was valued at USD 1.52 Billion in 2024 and is poised to grow from USD 1.75 Billion in 2025 to USD 5.52 Billion by 2033, growing at a CAGR of 15.32% during the forecast period (2026-2033).

The global market for automated and closed cell therapy processing systems is increasingly driven by the demand for scalable, safe manufacturing of advanced therapies, such as CAR T and stem cell treatments. These platforms integrate various processes, including cell isolation and formulation, within a contained environment to mitigate contamination risks and operator variability, which are critical for ensuring patient safety and consistent clinical outcomes. As the clinical pipeline for cell-based products expands, there is growing investment in standardized platforms that leverage automation to minimize variability and regulatory approval uncertainties. The integration of AI enhances operational efficiency by enabling predictive analytics, machine vision, and orchestration software. This technological progress supports the transition from pilot projects to full-scale production, thereby increasing capacity, reducing logistics challenges, and accelerating patient access.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Automated And Closed Cell Therapy Processing Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Automated And Closed Cell Therapy Processing Systems Market Segments Analysis

Global automated and closed cell therapy processing systems market is segmented by system type, technology, application, end-user and region. Based on system type, the market is segmented into Cell Isolation Systems, Cell Expansion Systems, Cell Washing & Formulation and Cryopreservation Systems. Based on technology, the market is segmented into Automated Platforms and Closed-Loop Systems. Based on application, the market is segmented into CAR-T Cell Manufacturing, NK Cell Therapy and Stem Cell Therapy. Based on end-user, the market is segmented into Cell Therapy Manufacturers, Academic Research Centers and CDMOs. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Automated And Closed Cell Therapy Processing Systems Market

One of the key market drivers for the Global Automated and Closed Cell Therapy Processing Systems Market is the increasing demand for advanced therapies in regenerative medicine and personalized treatment options. The growing prevalence of chronic diseases, along with advancements in cell therapy techniques, has accelerated the need for efficient and reliable processing systems. Automation enhances reproducibility, minimizes contamination risks, and improves overall productivity, making it essential for manufacturers looking to scale their operations. Furthermore, regulatory support for innovative medical technologies and rising investments in research and development are expected to further bolster market growth in this sector.

Restraints in the Global Automated And Closed Cell Therapy Processing Systems Market

A key market restraint for the Global Automated and Closed Cell Therapy Processing Systems Market is the high cost associated with the implementation and maintenance of advanced system technologies. These systems require significant investments in specialized equipment, training, and ongoing support, which can be a barrier for smaller healthcare facilities and research laboratories. Additionally, regulatory hurdles and concerns related to the standardization of automated processes can further complicate adoption, limiting market growth. As organizations weigh the benefits against the financial implications, the complexity and cost of integration may hinder wider implementation, stifling innovation and accessibility in cell therapy advancements.

Market Trends of the Global Automated And Closed Cell Therapy Processing Systems Market

The Global Automated and Closed Cell Therapy Processing Systems market is witnessing a significant trend towards standardization, which is enhancing scalability and operational efficiency. Industry-wide agreements on protocols, interfaces, and quality metrics are minimizing workflow inconsistencies and promoting modular interoperability across various platforms. This alignment among vendors and clinical experts on common data formats and validation frameworks is streamlining technology transfer processes, thereby fostering an ecosystem of reliable suppliers. As a result, operational friction is reduced, and regulatory discussions can concentrate on achieving consistent outcomes, enabling providers to confidently scale capacity and replicate successful therapies predictably and efficiently.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Automated And Closed Cell Therapy Processing Systems Market Size by System Type & CAGR (2026-2033)

• Market Overview
• Cell Isolation Systems
• Cell Expansion Systems
• Cell Washing & Formulation
• Cryopreservation Systems

Global Automated And Closed Cell Therapy Processing Systems Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Automated Platforms
• Closed-Loop Systems

Global Automated And Closed Cell Therapy Processing Systems Market Size by Application & CAGR (2026-2033)

• Market Overview
• CAR-T Cell Manufacturing
• NK Cell Therapy
• Stem Cell Therapy

Global Automated And Closed Cell Therapy Processing Systems Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Cell Therapy Manufacturers
• Academic Research Centers
• CDMOs

Global Automated And Closed Cell Therapy Processing Systems Market Size & CAGR (2026-2033)

• North America (System Type, Technology, Application, End-User)
  • US
  • Canada
• Europe (System Type, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (System Type, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (System Type, Technology, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (System Type, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Miltenyi Biotec (CliniMACS)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva (Danaher) - Sepax
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioSpherix Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wilson Wolf Manufacturing
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ori Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octane Biotech (Cytiva)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Multiply Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MaxCyte Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Cocoon Platform)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ThermoGenesis Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Global Blood Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellero (Novatek)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PCT (Hitachi)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAtla
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellipont Bioservices
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMPIO Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations